Sinopharm Group Co. Ltd.

Symbol: 1099.HK

HKSE

20.5

HKD

Market price today

  • 4.2750

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 63.93B

    MRK Cap

  • 0.05%

    DIV Yield

Sinopharm Group Co. Ltd. (1099-HK) Financial Statements

On the chart you can see the default numbers in dynamics for Sinopharm Group Co. Ltd. (1099.HK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Sinopharm Group Co. Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

balance-sheet.row.cash-and-short-term-investments

063809.155222.143541.2
50217.4
39192.1
40340.2
29187
25578.2
21196.4
16423.8
14876
9723.6
13092.2
7475.7
6937.3
1712.1
1955.6
1838.8

balance-sheet.row.short-term-investments

00.50.511.7
39.1
0.2
41.2
175.6
5.5
1230.4
1191.4
874.1
1.6
1.2
1
0
0
0
0

balance-sheet.row.net-receivables

0185790.4201909.9172575.5
146049.2
122628.6
106678.8
81304.3
75185.9
65382.5
66098.2
51824.7
41084.3
29728.3
19125.1
0
616.9
605.5
519.2

balance-sheet.row.inventory

060027.660925.851499.6
47085.4
42594.4
35388.9
26768.7
25759.5
22553.2
20308.6
16702.3
13618.1
12214.1
7530.4
4272.8
3154.8
2634.4
2043.4

balance-sheet.row.other-current-assets

01159.81348.520506
21664.2
23382.8
20604.2
17133.7
6236.1
8767.7
7441.9
6310.3
1590.4
1198.5
732.1
14077.2
8197.6
6759.8
4996.2

balance-sheet.row.total-current-assets

0336835.1319406.4290922.1
267610
229999.7
204654.6
144843.4
132759.7
117899.9
110272.5
89713.4
66016.3
56233.1
34863.3
25287.2
13681.5
11955.3
9397.6

balance-sheet.row.property-plant-equipment-net

018049.717792.417597.5
17065.9
16272
12692.5
9144.3
8081
7642.5
7102.3
6310.5
6399.5
4430.7
3330.8
1447.9
1257
1192.9
1088

balance-sheet.row.goodwill

07185.77155.67199
7287.4
5664.1
4899.4
4127.3
3834.9
3999.9
3723.9
3466
3397
0
0
0
0
0
0

balance-sheet.row.intangible-assets

04858.44870.15003
5271.8
5133.4
2598.3
2546.9
2447.9
2665.3
3993
3373.4
2152.5
5574.9
2257.1
895.5
607
601.8
613.7

balance-sheet.row.goodwill-and-intangible-assets

012044.112025.712202
12559.2
10797.5
7497.7
6674.2
6282.8
6665.2
7716.8
6839.4
5549.5
5574.9
2257.1
895.5
607
601.8
613.7

balance-sheet.row.long-term-investments

010550.798409172.5
8445.1
7859.4
7023.9
5528.7
4051.3
1455.7
1278.6
1005.4
951.2
727.7
541
330.8
359.4
312.3
252.2

balance-sheet.row.tax-assets

01963.71979.71787.1
1601.7
1448.9
1072.1
836.5
791.2
640.7
565.5
455.5
339.7
284
234.1
143.1
143
138.5
148.2

balance-sheet.row.other-non-current-assets

03951.637313731.1
3954.8
3511
2830.3
2512
5745.6
-640.7
-565.5
-455.5
590.9
377.5
788.3
170.7
67
86.4
90.7

balance-sheet.row.total-non-current-assets

046559.745368.844490.2
43626.7
39888.7
31116.5
24695.6
24951.9
15763.4
16097.7
14155.4
13830.8
11394.8
7151.2
2988
2433.4
2332
2192.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
5766.4
2285.6
1584.3
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0383394.8364775.1335412.3
311236.7
269888.4
235771.1
169539
157711.6
139429.7
128655.7
105453.1
79847.1
67627.9
42014.5
28275.3
16114.9
14287.3
11590.3

balance-sheet.row.account-payables

0154747.4144616.7132866.9
116731.6
108920.5
87715.7
69179.4
68845.5
59563.3
54723.7
44188.1
35137.5
27054
19831.2
12135
9053.1
7209.6
5629.8

balance-sheet.row.short-term-debt

05652754633.256699.7
56365.1
43668.9
50085.2
30162.9
22362.6
28204
25232.9
21007.3
10888.2
8666.8
3344.2
1284.3
1504.2
2161.6
1704.4

balance-sheet.row.tax-payables

02988.73278.73008.1
2574.3
2276.5
2061.4
1328.1
1275.5
960.7
901.7
741.6
618.5
289
232.6
83.7
96
114.9
63

balance-sheet.row.long-term-debt-total

017254.91495711668.5
12161.7
11470.3
5019.1
5525.1
11135.3
608.2
4222.6
4134.1
5191.6
5182.4
90.9
50
130
157.7
177.7

Deferred Revenue Non Current

0369.2413376.2
364.7
348.9
300.6
214.3
238.1
290.3
205.7
155.5
127.3
435.5
368.7
276.3
302.7
250.2
241.7

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

07495.635713.18119.6
8012.5
8419
22273.4
11534
1080.9
7854.5
6063.3
5645.8
281.9
4570.8
2578.7
1335.5
1320.5
1575.7
935.5

balance-sheet.row.total-non-current-liabilities

021585.51974316451.8
17312.3
14524.4
7420.9
7393.1
13441.8
608.2
4222.6
4134.1
6998.4
6948.2
1541.3
1015.9
826.5
722
730.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
2321.1
2123.7
1866.5
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

05217.44842.54797.9
4649.1
4289.7
67.9
83.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0263076.1254705.9235758.4
221289.4
192949
167495.3
118269.4
113179.2
98551
92366.1
76841.8
57103.9
47239.8
27295.4
15770.8
12704.3
11668.9
9000

balance-sheet.row.preferred-stock

01787.24390.64388.1
4307.6
4300.4
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

03120.73120.73120.7
3120.7
2971.7
2971.7
2767.1
2767.1
2767.1
2767.1
2568.3
2402.6
2402.6
2264.6
2264.6
0
0
0

balance-sheet.row.retained-earnings

049410.142870.138515.8
32908.1
27588
23089.7
21096.9
13437.5
10640.6
7800.1
5656.4
0
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-4373.3-4390.6-4388.1
-4307.6
-4300.4
0
0
-3376.4
0
0
0
-1711.2
-1248.9
-924.5
-593.5
0
0
0

balance-sheet.row.other-total-stockholders-equity

024637.622077.820249.6
20330.1
16862.4
16760.5
11393.6
18982.7
16702.6
16814.7
13590.9
16386.9
14520.1
10371.1
9239.8
2264.2
1683.8
1759.6

balance-sheet.row.total-stockholders-equity

074582.268068.661886
56358.8
47422.1
42821.8
35257.6
31810.9
30110.3
27381.9
21815.5
17078.3
15673.8
11711.1
10910.9
2264.2
1683.8
1759.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0383394.8364775.1335412.3
311236.7
269888.4
235771.1
169539
157711.6
138267
128655.7
105453.1
79847.1
67627.9
42014.5
28275.3
16114.9
14287.3
11590.3

balance-sheet.row.minority-interest

045736.542000.637767.9
33588.5
29517.2
25453.9
16012
12721.5
10768.4
8907.8
6795.8
5664.9
4714.2
3007.9
1593.6
1146.4
934.6
830.6

balance-sheet.row.total-equity

0120318.7110069.299653.9
89947.3
76939.4
68275.8
51269.7
44532.4
40878.7
36289.6
28611.3
22743.2
20388.1
14719.1
12504.5
3410.6
2618.3
2590.3

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

010550.79840.59184.3
8484.3
7859.6
7065.1
5704.3
4056.7
2686.1
2470
1879.5
952.7
728.9
542
330.8
359.4
312.3
252.2

balance-sheet.row.total-debt

073781.969590.268368.2
68526.8
55139.3
55104.3
35688
33497.9
28812.2
29455.5
25141.3
16079.8
13849.1
3435.1
1334.3
1634.2
2319.3
1882.1

balance-sheet.row.net-debt

09973.314368.624838.8
18348.6
15947.3
14805.3
6676.6
7925.1
8846.1
14223.1
11139.4
6357.8
758.1
-4039.6
-5602.9
-77.9
363.7
43.3

Cash Flow Statement

The financial landscape of Sinopharm Group Co. Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006

cash-flows.row.net-income

018563.817003.215598.1
13759.8
12207.9
10173
8924.8
3772.2
2874.8
2250
4014.3
3127.6
2398
1572.4
1077.4
820.4
364

cash-flows.row.depreciation-and-amortization

041653922.13597.1
3114.1
1394.7
1015.1
1067.8
915.7
759.5
620.1
565.6
460.1
300.5
201.6
172.7
134.9
126.7

cash-flows.row.deferred-income-tax

000-2547.1
-1865.8
0
0
-2569.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

000-18.6
5.8
20
26.9
3.8
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2073.7-12101.3-8720
464
-10665.3
-8843.7
-127.7
361.5
-16289.2
-15950.2
-615.4
-2327
-1036.9
-388.4
-389.4
-304
102.6

cash-flows.row.account-receivables

0710.1-26717.2-22631.4
-12965.4
-24392.2
-6654.1
-4852.2
2192.9
-12979.7
-13238.5
0
0
0
0
0
0
0

cash-flows.row.inventory

0-9504.2-4345.3-3675.4
-6120.2
-4925.9
-697.1
-3559.8
-1831.4
-3309.4
-2711.7
-1031.6
-3014.4
-1562.2
-968.1
-453.4
-586
-111.6

cash-flows.row.account-payables

0-710.126717.222631.4
12965.4
24392.2
6654.1
4852.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

07430.5-7756-5044.6
6584.2
-5739.5
-1492.5
8284.4
0
0
0
416.2
687.4
525.2
579.7
64
282
214.2

cash-flows.row.other-non-cash-items

0308.6484.23245
3299.3
696.5
-704
1958.6
8362.9
18215.7
18021.5
52.7
-241.5
-459
-374
-206.8
-210.2
45.2

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2417.5-2255.6-2087.3
-2548.8
-3404.1
-1894.7
-1363.8
-1020.8
-1450.5
-1128.3
-1519.3
-1129.5
-1530.8
-398.3
-305.9
-260.1
-260

cash-flows.row.acquisitions-net

0-336.7-488.4-2427.4
-1234.4
-295.1
-747.2
-419
-360.3
-1460.8
-970.4
-1012.1
-1936.5
-3002.3
66.6
65.2
95.8
-88.1

cash-flows.row.purchases-of-investments

0-100-75-40
-115.2
-537
-303.6
-9.2
-8.4
-15
-62.5
-73.1
-17.4
14.6
49.7
-36.6
-24.1
-1.5

cash-flows.row.sales-maturities-of-investments

0211.5298.623.7
55.2
60.1
24.8
1.4
116.5
1475.8
0.4
4.1
7.2
112.7
7
24.3
16.4
17

cash-flows.row.other-investing-activites

0-946.91253.42328.3
-2952.8
-1731.5
373.3
184.2
-370.3
-1431.3
-1905.6
391.9
245.4
2574.2
-2841.1
105.1
157.6
61.6

cash-flows.row.net-cash-used-for-investing-activites

0-3589.6-1267-2202.8
-6796
-5907.6
-2547.3
-1606.5
-1643.3
-4357.6
-4066.4
-2208.6
-2830.8
-1831.5
-3116.1
-148
-14.4
-270.9

cash-flows.row.debt-repayment

0-101705.3-104707.1-96838.2
-91298.7
-66762.6
-39075.8
-40252.3
-47056.1
-39034.7
-31436.6
-24970.4
-13166.5
-3657.6
-5672
-3816.6
-1691
-1732.8

cash-flows.row.common-stock-issued

0003600.4
50.2
2.8
-100
0
0
4390.7
3224.6
0
3270.2
143.1
8844.9
0
0
0

cash-flows.row.common-stock-repurchased

00096841.4
78854.5
0
-196.2
0
0
34643.9
28212
0
18349.8
4377.7
6488.4
0
0
0

cash-flows.row.dividends-paid

0-2340.5-2153.3-1865.1
-1753.3
-1577
-1383.4
-1134.5
-857.8
-667.8
-642.1
-456.5
-363.1
-22.9
-1074.1
-127.7
0
-101.5

cash-flows.row.other-financing-activites

098352.392167.4287.4
1062.8
78655.3
45057.8
39359.9
40754.2
35333.7
32262.8
20249.3
-662.5
-304.5
-1578
3195
1381
1954.2

cash-flows.row.net-cash-used-provided-by-financing-activities

0-5693.5-146932025.9
-13084.6
10318.5
4302.4
-2027
-7159.8
22
3408.7
-5177.6
7427.9
535.8
7009.3
-749.4
-310
119.8

cash-flows.row.effect-of-forex-changes-on-cash

011.538.6
-3.6
-6.4
16.2
-17.8
50.8
5.1
-83.2
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

011692.2-6648.810986.3
-1107
8058.2
3438.7
5606.7
4733.7
1230.4
4200.5
-3369
5616.3
-93.1
4904.7
-243.5
116.8
487.4

cash-flows.row.cash-at-end-of-period

055221.643529.450178.3
39192
40299
29011.4
25572.8
19966.1
15232.4
14002
9722
13091
7474.7
6616.8
1712.1
1955.6
1838.8

cash-flows.row.cash-at-beginning-of-period

043529.450178.339192
40299
32240.8
25572.8
19966.1
15232.4
14002
9801.5
13091
7474.7
7567.8
1712.1
1955.6
1838.8
1351.4

cash-flows.row.operating-cash-flow

020963.89308.111154.6
18777.1
3653.7
1667.3
9258
13412.3
5560.8
4941.3
4017.2
1019.3
1202.5
1011.5
653.8
441.2
638.4

cash-flows.row.capital-expenditure

0-2417.5-2255.6-2087.3
-2548.8
-3404.1
-1894.7
-1363.8
-1020.8
-1450.5
-1128.3
-1519.3
-1129.5
-1530.8
-398.3
-305.9
-260.1
-260

cash-flows.row.free-cash-flow

018546.37052.49067.3
16228.3
249.6
-227.4
7894.1
12391.5
4110.3
3813
2497.9
-110.3
-328.2
613.2
347.9
181.1
378.4

Income Statement Row

Sinopharm Group Co. Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 1099.HK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

income-statement-row.row.total-revenue

0596569.6552147.6521051.2
456414.6
425272.7
344525.8
277029
258117.2
228672.9
200131.3
166866.1
135786.8
102224.8
69233.7
47045.9
38187.4
31110.2
23736.6

income-statement-row.row.cost-of-revenue

0548057.9504713.5477000.6
416091.3
387741.4
313297.7
254640.5
237717
209952.6
183803
153487.6
124844.2
93870.1
63397.8
43261.3
35152.5
28560
21747.1

income-statement-row.row.gross-profit

048511.747434.144050.6
40323.3
37531.3
31228.1
22388.5
20400.2
18720.3
16328.2
13378.5
10942.6
8354.7
5835.9
3784.6
3035
2550.2
1989.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-41.8-676.2-589.2
-652
-441.2
-413.8
-399.8
4.9
1.5
22.8
-7.6
9.7
-168.9
171.4
171.2
92.7
124.1
-45.6

income-statement-row.row.operating-expenses

026234.72422722609.3
20539.6
19028
15474
11170.6
10457
9436.5
8401
7237.8
6079.3
4718.5
3427.1
2234.3
1862.8
1760.9
1509.3

income-statement-row.row.cost-and-expenses

0574292.6528940.4499610
436630.9
406769.4
328771.7
265811.1
248174
219389.1
192204.1
160725.4
130923.5
98588.6
66824.9
45495.6
37015.3
30320.9
23256.4

income-statement-row.row.interest-income

0743.4542.8558.6
676.4
519.4
513.4
1009.2
561.5
1814.7
1992.6
1520.2
148.8
115.5
76.4
23.8
24.3
17.8
11.7

income-statement-row.row.interest-expense

02956.63520.33756.8
3424.8
3442.5
4157.3
2611.9
2043.5
2087
2191.2
1730.6
1317.4
933.5
348.6
239.8
266
150.9
101.5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-2806.3-2040.6-2708.8
-2161.9
-2376.9
-3188.9
-1733
-1288.9
-1740.1
-1916.6
-1461.3
-849.1
-508.6
-10.9
22.1
-94.7
31.1
-116.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-41.8-676.2-589.2
-652
-441.2
-413.8
-399.8
4.9
1.5
22.8
-7.6
9.7
-168.9
171.4
171.2
92.7
124.1
-45.6

income-statement-row.row.total-operating-expenses

0-2806.3-2040.6-2708.8
-2161.9
-2376.9
-3188.9
-1733
-1288.9
-1740.1
-1916.6
-1461.3
-849.1
-508.6
-10.9
22.1
-94.7
31.1
-116.3

income-statement-row.row.interest-expense

02956.63520.33756.8
3424.8
3442.5
4157.3
2611.9
2043.5
2087
2191.2
1730.6
1317.4
933.5
348.6
239.8
266
150.9
101.5

income-statement-row.row.depreciation-and-amortization

04430.28204.87153.1
7145.6
6662.8
2670.6
1525.6
1067.8
915.7
759.5
620.1
565.6
460.1
300.5
201.6
172.7
134.9
126.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

020209.220604.519712
17760
16136.7
15396.8
11906
10213.7
9209.3
7851.2
6081.8
4863.3
3636.2
2408.8
1550.3
1172.1
789.3
480.3

income-statement-row.row.income-before-tax

019512.118563.817003.2
15598.1
13759.8
12207.9
10173
8924.8
7469.2
5934.6
4620.5
4014.3
3127.6
2398
1572.4
1077.4
820.4
364

income-statement-row.row.income-tax-expense

04502.34218.43938.4
3500.8
3139.7
2803.5
2304.8
2033.2
1728.3
1383
1040.8
934.1
725
567.6
386.2
259.3
284.5
181.5

income-statement-row.row.net-income

09053.814345.413064.8
12097.3
10620.1
9404.5
7868.2
4647.3
3760.6
2874.8
2250
1973.8
1560.6
1208.8
845.8
818.1
535.9
182.4

Frequently Asked Question

What is Sinopharm Group Co. Ltd. (1099.HK) total assets?

Sinopharm Group Co. Ltd. (1099.HK) total assets is 383394844000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.084.

What is company free cash flow?

The free cash flow is 22.484.

What is enterprise net profit margin?

The net profit margin is 0.015.

What is firm total revenue?

The total revenue is 0.038.

What is Sinopharm Group Co. Ltd. (1099.HK) net profit (net income)?

The net profit (net income) is 9053760000.000.

What is firm total debt?

The total debt is 73781852000.000.

What is operating expences number?

The operating expences are 26234719000.000.

What is company cash figure?

Enretprise cash is 0.000.